Bourne CM - Search Results

1

Distinct sequential death complexes regulate pyroptosis and IL-1β release in response to Yersinia blockade of immune signaling.

Wertman RS, Yost W, Herrmann BI, Bourne CM, Sorobetea D, Go CK, Saller BS, Groß O, Scott P, Rongvaux A, Taabazuing CY, Brodsky IE. Wertman RS, et al. Among authors: bourne cm. Sci Adv. 2024 Jul 26;10(30):eadl3629. doi: 10.1126/sciadv.adl3629. Epub 2024 Jul 26. Sci Adv. 2024. PMID: 39058785 Free PMC article.

2

Inflammatory caspase substrate specificities.

Exconde PM, Bourne CM, Kulkarni M, Discher BM, Taabazuing CY. Exconde PM, et al. Among authors: bourne cm. mBio. 2024 Jul 17;15(7):e0297523. doi: 10.1128/mbio.02975-23. Epub 2024 Jun 5. mBio. 2024. PMID: 38837391 Free PMC article. Review.

3

Harnessing Pyroptosis for Cancer Immunotherapy.

Bourne CM, Taabazuing CY. Bourne CM, et al. Cells. 2024 Feb 16;13(4):346. doi: 10.3390/cells13040346. Cells. 2024. PMID: 38391959 Free PMC article. Review.

4

The tetrapeptide sequence of IL-18 and IL-1β regulates their recruitment and activation by inflammatory caspases.

Exconde PM, Hernandez-Chavez C, Bourne CM, Richards RM, Bray MB, Lopez JL, Srivastava T, Egan MS, Zhang J, Yoo W, Shin S, Discher BM, Taabazuing CY. Exconde PM, et al. Among authors: bourne cm. Cell Rep. 2023 Dec 26;42(12):113581. doi: 10.1016/j.celrep.2023.113581. Epub 2023 Dec 15. Cell Rep. 2023. PMID: 38103201 Free PMC article.

5

Host Interactions with Engineered T-cell Micropharmacies.

Bourne CM, Wallisch P, Dacek MM, Gardner TJ, Pierre S, Vogt K, Corless BC, Bah MA, Romero-Pichardo JE, Charles A, Kurtz KG, Tan DS, Scheinberg DA. Bourne CM, et al. Cancer Immunol Res. 2023 Sep 1;11(9):1253-1265. doi: 10.1158/2326-6066.CIR-22-0879. Cancer Immunol Res. 2023. PMID: 37379366 Free PMC article.

6

Host-cell Interactions of Engineered T cell Micropharmacies.

Bourne CM, Wallisch P, Dacek M, Gardner T, Pierre S, Vogt K, Corless BC, Bah MA, Romero Pichardo J, Charles A, Kurtz KG, Tan DS, Scheinberg DA. Bourne CM, et al. bioRxiv [Preprint]. 2023 May 1:2023.04.05.535717. doi: 10.1101/2023.04.05.535717. bioRxiv. 2023. Update in: Cancer Immunol Res. 2023 Sep 1;11(9):1253-1265. doi: 10.1158/2326-6066.CIR-22-0879 PMID: 37205431 Free PMC article. Updated. Preprint.

7

Black in Cancer: Two Years of Empowering the Next Generation.

Bourne CM, Henderson HJ, White E, Morris J, Bah MA, Harewood R, Pierre S, Martins T, Ntereke T, White B, Bonner S. Bourne CM, et al. Cancer Discov. 2023 Feb 6;13(2):275-277. doi: 10.1158/2159-8290.CD-22-1408. Cancer Discov. 2023. PMID: 36744318

8

Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blocker.

Dacek MM, Kurtz KG, Wallisch P, Pierre SA, Khayat S, Bourne CM, Gardner TJ, Vogt KC, Aquino N, Younes A, Scheinberg DA. Dacek MM, et al. Among authors: bourne cm. Blood. 2023 Apr 20;141(16):2003-2015. doi: 10.1182/blood.2022016101. Blood. 2023. PMID: 36696633 Free PMC article.

9

Regulators of the secretory pathway have distinct inputs into single-celled branching morphogenesis and seamless tube formation in the Drosophila trachea.

Bourne CM, Lai DC, Schottenfeld-Roames J. Bourne CM, et al. Dev Biol. 2022 Oct;490:100-109. doi: 10.1016/j.ydbio.2022.07.005. Epub 2022 Jul 20. Dev Biol. 2022. PMID: 35870495 Free article.

10

Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment.

Bourne CM, Mun SS, Dao T, Aretz ZEH, Molvi Z, Gejman RS, Daman A, Takata K, Steidl C, Klatt MG, Scheinberg DA. Bourne CM, et al. Blood Adv. 2022 Jul 26;6(14):4107-4121. doi: 10.1182/bloodadvances.2021006069. Blood Adv. 2022. PMID: 35561310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters